Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice

Robert P. Hebbel, Gregory M. Vercellotti, Betty S. Pace, Anna N. Solovey, Rahn Kollander, Chine F. Abanonu, Julia Nguyen, Julie V. Vineyard, John D. Belcher, Fuad Abdulla, Shadé Osifuye, John W. Eaton, Robert J. Kelm, Jr, Arne Slungaard

Blood (2010) 115 (12): 2483–2490.

https://doi.org/10.1182/blood-2009-02-204990

Published: 2010

Journal Articles

The HDAC Inhibitors Trichostatin A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA) Exhibit Multiple Modalities of Benefit for the Vascular Pathology of Sickle Disease.

Robert P Hebbel, MD, Gregory M. Vercellotti, MD, Betty Pace, MD, Anna Solovey, M.D., Rahn Kollander, Chine Abanonu, Julia Nguyen, BS, Julie V. Vineyard, BS, John D Belcher, Ph.D., Fuad Abdulla, Shade Osifuye, John W. Eaton, PhD, Robert Kelm, MD, Arne Slungaard, MD

Blood (2009) 114 (22): 2586.

https://doi.org/10.1182/blood.V114.22.2586.2586

Published: 2009

Journal Articles

Pro-oxidant and cytotoxic effects of circulating heme

Viktória Jeney, József Balla, Akihiro Yachie, Zsuzsa Varga, Gregory M. Vercellotti, John W. Eaton, György Balla

Blood (2002) 100 (3): 879–887.

https://doi.org/10.1182/blood.V100.3.879

Published: 2002

Journal Articles

Molecular basis of biomaterial-mediated foreign body reactions

Wen-Jing Hu, John W. Eaton, Tatiana P. Ugarova, Liping Tang

Blood (2001) 98 (4): 1231–1238.

https://doi.org/10.1182/blood.V98.4.1231

Published: 2001

Journal Articles

Stealth Cells: Prevention of Major Histocompatibility Complex Class II-Mediated T-Cell Activation by Cell Surface Modification

Kari L. Murad, Edmund J. Gosselin, John W. Eaton, Mark D. Scott

Blood (1999) 94 (6): 2135–2141.

https://doi.org/10.1182/blood.V94.6.2135

Published: 1999

Journal Articles

Structural and Functional Consequences of Antigenic Modulation of Red Blood Cells With Methoxypoly(Ethylene Glycol)

Kari L. Murad, Kathleen L. Mahany, Carlo Brugnara, Frans A. Kuypers, John W. Eaton, Mark D. Scott

Blood (1999) 93 (6): 2121–2127.

https://doi.org/10.1182/blood.V93.6.2121.406a30_2121_2127

Published: 1999

Journal Articles

Artificially Induced Thyroid Suppression in Sickle Cell Disease

Charles W. Seward, M.D., John W. Eaton, Ph.D., Hugh Chaplin, Jr., M.D.

Blood (1972) 40 (6): 905–913.

https://doi.org/10.1182/blood.V40.6.905.905

Published: 1972

NARROW

The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice

The HDAC Inhibitors Trichostatin A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA) Exhibit Multiple Modalities of Benefit for the Vascular Pathology of Sickle Disease.

Pro-oxidant and cytotoxic effects of circulating heme

Molecular basis of biomaterial-mediated foreign body reactions

Stealth Cells: Prevention of Major Histocompatibility Complex Class II-Mediated T-Cell Activation by Cell Surface Modification

Structural and Functional Consequences of Antigenic Modulation of Red Blood Cells With Methoxypoly(Ethylene Glycol)

Artificially Induced Thyroid Suppression in Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice

The HDAC Inhibitors Trichostatin A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA) Exhibit Multiple Modalities of Benefit for the Vascular Pathology of Sickle Disease.

Pro-oxidant and cytotoxic effects of circulating heme

Molecular basis of biomaterial-mediated foreign body reactions

Stealth Cells: Prevention of Major Histocompatibility Complex Class II-Mediated T-Cell Activation by Cell Surface Modification

Structural and Functional Consequences of Antigenic Modulation of Red Blood Cells With Methoxypoly(Ethylene Glycol)

Artificially Induced Thyroid Suppression in Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only